Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhibitory effect of proretinal nanoparticle on facial sebum production
TCTR20190709002Phase 2Completed
- Sponsor
- Division of Dermatology, Chulalongkorn University
- Start
- Aug 2019
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in seborrheic dermatitis (SD) (2 arms), sponsored by Division of Dermatology, Chulalongkorn University. Primary endpoint: Change in facial sebum production. Started Aug 2019; status: completed.
02
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on TCTR20190709002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190709002.